Roch Houot
Impact in
- Oncology top 0.5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 111
- CAR-T cell therapy research 81
- Cancer Immunotherapy and Biomarkers 22
-
- Lymphoma Diagnosis and Treatment 81
- Co-authors
- Aurélien Marabelle (11 shared papers)Ronald Levy (32 shared papers)Holbrook E. Kohrt (23 shared papers)Lambros Tselikas (1 shared paper)Thierry de Baère (1 shared paper)Guillaume Manson (15 shared papers)Ash A. Alizadeh (12 shared papers)June H. Myklebust (10 shared papers)
- Journals
- Blood (54 papers)Journal of Clinical Oncology (23 papers)Annals of Oncology (11 papers)European Journal of Cancer (9 papers)Blood Advances (6 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Roch Houot
173 papers receiving 4.3k citations
Roch Houot's Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 2.5k
- Pathology and Forensic Medicine 1.4k
- Immunology 1.7k
- Genetics 536
- Hematology 223
Countries citing papers authored by Roch Houot
This map shows the geographic impact of Roch Houot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roch Houot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roch Houot more than expected).
Fields of papers citing papers by Roch Houot
This network shows the impact of papers produced by Roch Houot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roch Houot. The network helps show where Roch Houot may publish in the future.
Co-authors
The 25 scholars most cited alongside Roch Houot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 185 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 271 | |
| 2 | 2017 | 161 | |
| 3 | 2015 | 155 | |
| 4 | 2011 | 146 | |
| 5 | 2008 | 142 | |
| 6 | 2016 | 134 | |
| 7 | 2013 | 133 | |
| 8 | 2010 | 129 | |
| 9 | 2016 | 126 | |
| 10 | 2016 | 115 | |
| 11 | 2007 | 108 | |
| 12 | 2010 | 105 | |
| 13 | 2009 | 104 | |
| 14 | 2018 | 100 | |
| 15 | 2006 | 96 | |
| 16 | 2017 | 89 | |
| 17 | 2021 | 83 | |
| 18 | 2021 | 82 | |
| 19 | 2013 | 80 | |
| 20 | 2012 | 75 |
About Roch Houot
Roch Houot is a scholar working on Oncology, Pathology and Forensic Medicine, Immunology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 185 papers that have together received 4.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (81 papers), Lymphoma Diagnosis and Treatment (81 papers), Chronic Lymphocytic Leukemia Research (37 papers), Immune Cell Function and Interaction (26 papers), Cancer Immunotherapy and Biomarkers (22 papers), Monoclonal and Polyclonal Antibodies Research (20 papers), Immunotherapy and Immune Responses (19 papers) and Acute Lymphoblastic Leukemia research (10 papers). The work is most often cited by research in Oncology (2.5k citations), Pathology and Forensic Medicine (1.4k citations), Immunology (1.7k citations), Genetics (536 citations) and Hematology (223 citations). Roch Houot has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Aurélien Marabelle, Ronald Levy, Holbrook E. Kohrt, Lambros Tselikas, Thierry de Baère, Guillaume Manson, Ash A. Alizadeh, June H. Myklebust, Jean Lemoine and Marion Alcantara. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.